Recent national and regional drug reforms in Sweden: Implications for pharmaceutical companies in Europe

Björn Wettermark, Brian Godman*, Karolina Andersson, Lars L. Gustafsson, Alan Haycox, Vittorio Bertelé

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

64 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Recent national and regional drug reforms in Sweden: Implications for pharmaceutical companies in Europe'. Together they form a unique fingerprint.

Social Sciences

Medicine & Life Sciences